Chiral Phosphoric Acid Catalyzed Enantioselective Transfer

Jun 22, 2012 - Chiral Phosphoric Acid Catalyzed Enantioselective Transfer Deuteration of Ketimines by Use of Benzothiazoline As a Deuterium Donor: Syn...
5 downloads 9 Views 1MB Size

Chiral Phosphoric Acid Catalyzed Enantioselective Transfer Deuteration of Ketimines by Use of Benzothiazoline As a Deuterium Donor: Synthesis of Optically Active Deuterated Amines

2012 Vol. 14, No. 13 3312–3315

Tsubasa Sakamoto, Keiji Mori, and Takahiko Akiyama* Department of Chemistry, Faculty of Science, Gakushuin University, 1-5-1 Mejiro, Toshima-ku, Tokyo 171-8588, Japan [email protected] Received May 9, 2012


By use of 2-deuterated benzothiazoline as a deuterium donor in combination with a chiral phosphoric acid, the transfer deuteration of ketimine and R-iminoester took place smoothly to give R-deuterated amines in high yields with excellent enantioselectivities. The remarkable kinetic isotope effect suggests that carbon deuterium bond cleavage is the rate-determining step.

Deuterated compounds are an important class of materials that are used in various areas, including the analysis of the metabolic pathways of bioactive compounds,1a,b the determination of the mechanisms of both chemical and enzymatic reactions,1c,d and NMR solvents. Recently, ‘heavy drugs’ have emerged as novel drugs that exhibit better stability and/or bioavailability than their hydrogen analogs.2 For instance, the deuterium substitution on the methylenedioxy moiety of deuterated paroxetine,3 an antidepressant, altered the drug’s metabolism and prolonged its activity in vivo. Telaprevir is generally acknowledged as an inhibitor of the hepatitis C virus; however, the chiral center next to R-ketoamide (1) (a) Nelson, S. D.; Trager, W. F. Drug Metab. Dispos. 2003, 31, 1481–1498. (b) Hall, L. R.; Hanzlik, R. P. J. Biol. Chem. 1990, 265, 12349–12355. (c) Haesler, J.; Schindelholz, I.; Riguet, E.; Bochet, C. G.; Hug, W. Nature 2007, 446, 526–529. (d) MacDonald, D.; Lu, P. J. Am. Chem. Soc. 2002, 124, 9722–9723. (2) (a) Sanderson, K. Nature 2009, 458, 269. (b) Meanwell, N. A. J. Med. Chem. 2011, 54, 2529–2591. (3) For the press release of Concert Pharmaceuticals on September 14th, 2009, see: 10.1021/ol3012869 r 2012 American Chemical Society Published on Web 06/22/2012

(S-configuration) in telaprevir tends to epimerize to furnish an (R)-diastereoisomer that has ∼30-fold lower activity. Through the deuteration of telaprevir, the epimerization of telaprevir-d1 is retarded due to the presence of deuterium (Figure 1).4 In both cases, the introduction of deuterium improved the bioavailability. The significance of deuteration has been growing at a rapid pace. A number of practical methods for the (4) Maltais, F.; Jung, Y. C.; Chen, M.; Tanoury, J.; Perni, R. B.; Mani, N.; Laitinen, L.; Huang, H.; Liao, S.; Gao, H.; Tsao, H.; Block, E.; Ma, C.; Shawgo, R. S.; Town, C.; Brummel, C. L.; Howe, D.; Pazhanisamy, S.; Raybuck, S.; Namchuk, M.; Bennani, Y. L. J. Med. Chem. 2009, 52, 7993–8001. (5) (a) Martins, A.; Lautens, M. Org. Lett. 2008, 10, 4351–4353. (b) Erdogan, G.; Grotjahn, D. B. J. Am. Chem. Soc. 2009, 131, 10354– 10355. (c) Atzrodt, J.; Derdau, V.; Fey, T.; Zimmermann, J. Angew. Chem., Int. Ed. 2007, 46, 7744–7765. (d) Campos, J.; Esqueda, A. C.;  L opez-Serrano, J.; Sanchez, L.; Cossio, F. P.; de Cozar, A.; Alvarez, E.; Maya, C.; Carmona, E. J. Am. Chem. Soc. 2010, 132, 16765–16767. (e) Nave, S.; Sonawane, R. P.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2010, 132, 17096–17098. (f) Mohrig, J. R.; Reiter, N. J.; Kirk, R.; Zawadski, M. R.; Lamarre-Vincent, N. J. Am. Chem. Soc. 2011, 133, 5124–5128. (g) Imada, Y.; Iida, H.; Kitagawa, T.; Naota, T. Chem.; Eur. J. 2011, 17, 5908–5920.

the reactivity and enantioselectivity by changing the substituent at the 2-position of benzothiazoline (Figure 2).14 We hypothesized that the use of deuterated benzothiazoline, which is readily accessible from D1-aldehyde, would enable efficient access to optically active deuterated amines (Scheme 1).

Figure 2. Benzothiazoline. Figure 1. Deuterated pharmaceuticals.

deuteration, such as catalytic deuteration, conventional deuteride reduction, and a H D exchange reaction, have been reported.5 Although Yamada and co-workers reported the enantioselective reduction of aldimine with NaBD4,6 asymmetric deuteration is underexplored. We focused on the deuteride reduction of imine6,7 as a versatile reaction for the preparation of chiral R-deuterated amine.8 The enantioselective transfer hydrogenation of ketimines by the combined use of Hantzsch ester and chiral phosphoric acid has emerged as a useful method for the preparation of chiral amines.9 On the other hand, we demonstrated that benzothiazoline10 functioned as a novel hydrogen donor for the asymmetric transfer hydrogenation of ketimines11 by means of chiral phosphoric acid.12,13 The advantages of benzothiazoline are twofold: (1) benzothiazoline can be easily synthesized by mixing 2aminothiophenol and aldehyde; and (2) the ease of tuning (6) For an example of enantioselective deuteration by use of NaBD4, see: Miyazaki, D.; Nomura, K.; Yamashita, T.; Iwakura, I.; Ikeno, T.; Yamada, T. Org. Lett. 2003, 5, 3555–3558. (7) For the use of deuterated Hantzsch ester in the nonasymmetric reaction, see: Fujii, M.; Aida, T.; Yoshihara, M.; Ohno, A. Bull. Chem. Soc. Jpn. 1989, 62, 3845–3847. (8) (a) Meyers, A. I.; Dickman, D. A. J. Am. Chem. Soc. 1987, 109, 1263–1265. (b) Lown, J. W.; Akhtar, M. H. J. Chem. Soc., Chem. Commun. 1973, 511–513. (c) Battersby, A. R.; Staunton, J.; Summers, M. C. J. Chem. Soc., Perkin Trans. 1 1976, 1052–1056. (9) For reviews, see: (a) Zheng, C.; You, S.-L. Chem. Soc. Rev. 2012, 41, 2498–2518. (b) Rueping, M.; Sugiono, E.; Schoepke, F. R. Synlett 2010, 852–865. (c) Rueping, M.; Dufour, J.; Schoepke, F. R. Green Chem. 2011, 13, 1084–1105. (10) Chikashita, H.; Miyazaki, M.; Itoh, K. J. Chem. Soc., Perkin Trans. 1 1987, 699–706. (11) (a) Zhu, C.; Akiyama, T. Org. Lett. 2009, 11, 4180–4183. (b) Zhu, C.; Akiyama, T. Adv. Synth. Catal. 2010, 352, 1846–1850. (c) Henseler, A.; Kato, M.; Mori, K.; Akiyama, T. Angew. Chem., Int. Ed. 2011, 50, 8180–8183. (d) Saito, K.; Akiyama, T. Chem. Commun. 2012, 48, 4573–4575. See also: (e) Zhu, C.; Falck, J. R. ChemCatChem 2011, 3, 1850–1851. (12) For seminal work, see: (a) Akiyama, T.; Itoh, J.; Yokota, K.; Fuchibe, K. Angew. Chem., Int. Ed. 2004, 43, 1566–1568. (b) Uraguchi, D.; Terada, M. J. Am. Chem. Soc. 2004, 126, 5356–5357. (13) For selected reviews, see: (a) Akiyama, T.; Itoh, J.; Fuchibe, K. Adv. Synth. Catal. 2006, 348, 999–1010. (b) Akiyama, T. Chem. Rev. 2007, 107, 5744–5758. (c) Terada, M. Synthesis 2010, 1929–1982. (d) Rueping, M.; Kuenkel, A.; Atodiresei, I. Chem. Soc. Rev. 2011, 40, 4539–4549. (e) Yu, J.; Shi, F.; Gong, L.-Z. Acc. Chem. Res. 2011, 44, 1156–1171. Org. Lett., Vol. 14, No. 13, 2012

Scheme 1. Synthesis of Chiral Deuterated Amine

At the outset, we tried to perform the deuteride reduction of ketimine.11a On treatment of ketimine 2a with 2-deuterio-2-(2-naphthyl)benzothiazoline (3a) in the presence of a catalytic amount of chiral phosphoric acid 1 in mesitylene at 50 °C, the transfer deuteration proceeded to give corresponding R-deuterated amine 4a with excellent enantioselectivity. Deuterium was incorporated at the R-position of nitrogen (Scheme 2).

Scheme 2. Transfer Deuteration of Ketimine by Use of D-Benzothiazoline

(14) Zhu, C.; Akiyama, T. Synlett 2011, 1251–1254. 3313

The kinetic isotope effect (kH/kD = 3.8) was observed in the competitive reaction between H- and D-benzothiazolines, which clearly implies that cleavage of the C H bond is the rate-limiting step (Scheme 3).

Table 1. Optimization of Conditions for Asymmetric Deuteration of Ketimine by Use of D-Benzothiazoline

Scheme 3. Competition Experiment between H- and D-Benzothiazolines



yield of 4a/%a

ee of 4a/%b

yield of 5/%a

1 2c 3d 4e

32 28 42 26

45 50 44 quant

98 97 97 98

21 15 22 0


Isolated yield. b Determined by HPLC analysis on a chiral stationary phase using Daicel Chiralcel OD-H column. c MgSO4 was added. d At 70 °C. e MS 5 A was added.

We propose the reaction mechanism shown in Figure 3. Phosphoric acid activates ketimine as a Brønsted acid, and phosphoryl oxygen forms a hydrogen bond with N H of benzothiazoline. Then, the D-atom attacks ketimine as a deuteride.

Figure 3. Proposed reaction mechanism.

An acetal exchange between ketimine and D-benzothiazoline and a subsequent deuteride reduction proceeded to give 5 as the byproduct. We investigated this deuteride reduction in an effort to improve the yield of R-deuterated amine 4a by suppressing the exchange reaction (Table 1). Although the addition of a dehydrating reagent and the increase in temperature were not effective in improving the yields (entries 2 and 3), the addition of MS 5 A had a beneficial effect, furnishing 4a quantitatively (entry 4). With the optimized reaction conditions in hand, we investigated the substrate scope of the reaction (Table 2). We could obtain optically active R-deuterated amines in high yields and with excellent enantioselectivities in all the cases examined. The deuteride reduction was successfully applied to R-iminoesters (Table 3). 2-Deuterio-2-phenylbenzothiazoline proved to be the most effective hydrogen donor to give corresponding R-amino R-aryl acetates with excellent enantioselectivities. 3314

Table 2. Asymmetric Deuteration of Ketimines 2 by Use of D-Benzothiazoline 3a






1 2 3 4 5 6 7c 8

Ph 2-naphthyl p-tolyl p-MeOC6H4 p-FC6H4 p-ClC6H4 p-NO2C6H4 m-NO2C6H4

26 24 24 24 20 26 25 20

quant 90 93 91 71 97 77 84

98 98 98 97 98 97 95 97

a Isolated yield. b Determined by HPLC analysis on a chiral stationary phase using Daicel Chiralcel OD-H column and Daicel Chiralpak AD-H column. c MS 13 X was employed instead of MS 5 A.

Enantiomerically pure deuterated amine 4b could be obtained by a single recrystallization from hexane. The p-methoxyphenyl group of 4b was oxidatively cleaved by trichloroisocyanuric acid (TCCA),15 and the adduct was isolated as N-Boc amine 8 in good yield and in optically pure form (Scheme 4). The absolute configuration of deuterated R-aminoester 7a was determined to be (S) by X-ray crystallographic analysis of 4-bromobenzoate 9 (Scheme 5). As an application of the present methodology, deuterated oxazolidinone 11 was prepared starting from 7a by (15) Verkade, J. M. M.; van Hemert, L. J. C.; Quaedflieg, P. J. L. M.; Alsters, P. L.; van Delft, F. L.; Rutjes, F. P. J. T. Tetrahedron Lett. 2006, 47, 8109–8113. Org. Lett., Vol. 14, No. 13, 2012

Table 3. Asymmetric Deuteration of Iminoesters 6 by Use of D-Benzothiazoline 3b






1 2 3 4 5 6 7c 8d 9

Ph 2-naphthyl p-tolyl p-MeOC6H4 o-FC6H4 m-FC6H4 p-FC6H4 p-NO2C6H4 2-thienyl

4 13 13 9 4 5 15 3 15

94 quant 91 96 96 77 81 99 95

97 97 96 94 99 97 93 92 90

Scheme 5. Preparation of 4-Bromobenzoate 9

Scheme 6. Transformation to Oxazolidinone Bearing Deuterium Atom

a Isolated yield. b Determined by HPLC analysis on a chiral stationary phase using Daicel Chiralcel OJ-H column and Daicel Chiralpak AS-H, AD-H column. c Imine was generated in situ. d At 30 °C.

Scheme 4. Deprotection of p-Methoxyphenyl Group on Nitrogen Atom

donor in combination with chiral phosphoric acid. The large kinetic isotope effect (kH/kD = 3.8) indicates that cleavage of the carbon deuterium bond is the ratedetermining step. Acknowledgment. This work was partially supported by a Grant-in Aid for Scientific Research on Innovative Areas “Advanced Transformation by Organocatalysis” from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a Grant-in Aid for Scientific Research from the Japan Society for the Promotion of Science.

LiAlH4 reduction followed by exposure to triphosgene (Scheme 6). In summary, we developed a novel method for the transfer deuteration of ketimines with excellent enantioselectivities by use of benzothiazoline as the deuterium

Org. Lett., Vol. 14, No. 13, 2012

Supporting Information Available. Experimental procedures, characterization data, cif file of compound 9, and copies of NMR and HPLC spectra. This material is available free of charge via the Internet at The authors declare no competing financial interest.